Bizarre Patents
Crispy Chip Sandwich and Process of Producing a Sandwich Product
A food product comprising a multilayer cookie or snack having outer layers formed from a crispy type edible food product such as a potato chip or corn chip, etc. with an intermediate marshmallow layer being in contact with the inner surface of each crispy chip and one or more filler substances.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5563168 | O-Benzyloxime ethers and crop protection agents containing these compounds O-Benzyloxime ethers of the formula I ##STR1## where 5 X is substituted or unsubstituted CH2, NOalkyl Y is O, S, NR5 R1, R2, R5 are H, alkyl Z1, Z2 are H, halogen, methyl, methoxy, cy... | 10/08/1996 |
| 5559150 | N,N-disulfonylated aminobenzene carboxlic acids and the use thereof as thrombin inhibitors The present invention is directed to novel compounds that are non-peptidic thrombin inhibitors. The compounds have the structure: ##STR1## and pharmaceutically acceptable salts thereof; wherein R1 is one of alkyl, substituted alkyl, cycloa... | 09/24/1996 |
| 5559144 | Furyl and thienyl alkynyl-N-hydroxy urea derivatives Compounds of the structure ##STR1## where p and q are zero or one, but cannot both be the same, M is a pharmaceutically acceptable cation or a metabolically cleavable group, B is a valence bond or a straight or branched alkylene group, R is alkyl, ... | 09/24/1996 |
| 5556877 | Taxoids, their preparation and the pharmaceutical compositions which contain them This invention relates to taxoids of general formula (I), their preparation and the pharmaceutical compositions which contain them. The products of general formula (I) have notable antitumoral properties. In the general formula (I), Ar represents an aryl ... | 09/17/1996 |
| 5554633 | Substituted amines as tachykinin receptor antagonists Compounds of formula (I), and salts and prodrugs thereof, wherein Q is optionally substituted phenyl or benzhydryl; X and Y are each H or together form a group=O; Z is O, S or NR9, where R9 is H or C1-6 alkyl; R1 | 09/10/1996 |
| 5547969 | Method for the treatment of bradyphrenia in Parkinson's disease patients The neuropsychiatric symptom of bradyphrenia in a Parkinson's Disease patient may be ameliorated by treating the patient with a histamine H2 -antagonist that passes the blood brain barrier. Suitable H2 -antagonists include famotidine... | 08/20/1996 |
| 5543425 | Method of inhibiting platelet aggregation using phenyl amidine thio derivatives This invention relates to a method of inhibiting platelet aggregation comprising administering compounds having the following formula ##STR1##... | 08/06/1996 |
| 5543433 | Azine-substituted phenylacetic acid derivatives and fungicides containing these Compounds of the formula I ##STR1## where X is hydrogen, halogen, alkyl, alkoxy, trifluoromethyl, cyano or nitro, Y is an amino, methylamino or dimethylamino group, Z is a group CHCH3, CHOCH3 or NOCH3, R is hydrogen or alk... | 08/06/1996 |
| 5536746 | Insecticidal phenylhydrazine derivatives Compounds having the structural formula ##STR1## where X, Y, R and Z are defined in the specification are disclosed. The compounds of this invention are effective for controlling mites, nematodes, rice planthopper, tobacco budworm, and southern corn ... | 07/16/1996 |
| 5532267 | Amidinonaphthyl furancarboxylate derivatives and acid addition salts therof Amidinonaphthyl furancarboxylate derivatives of the formula I ##STR1## wherein A is a single bond or A denotes (a) a phenyl group, cyclopentyl group, or cyclohexyl group, (b) an alkenylphenyl group, alkylphenyl group, phenylalkenyl group, or phenylal... | 07/02/1996 |
| 5516789 | Lipoxygenase and cyclooxygenase inhibiting compounds Compounds having the structure ##STR1## or a pharmaceutically acceptable salt thereof have activity as inhibitors of cylooxygenase and 5-lipoxygenase, reduce the biosynthesis of leukotrienes B4, C4, D4, and E4 | 05/14/1996 |
| 5514702 | Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity The present invention provides certain (substituted carbocyclic aryl)amidoalkyl- and (substituted heterocyclic aryl)amidoalkyl-N-Hydroxy urea compounds which inhibit lipoxygenase enzyme activity and are thus useful in the treatment of allergic and inflamm... | 05/07/1996 |
| 5514694 | Peptidyl ketoamides A novel class of peptide -ketoamides useful for selectively inhibiting serine proteases, selectively inhibiting cysteine proteases, generally inhibiting all serine proteases, and generally inhibiting all cysteine proteases, having the formula Y--CO... | 05/07/1996 |
| 5502079 | N-phenylalkyl substituted -amino carboxamide derivatives and process for their preparation N-phenylalkyl substituted -amino carboxamide derivatives of formula (I) ##STR1## wherein R is C1 -C8 alkyl, C3 -C8 cycloalkyl, furyl, thienyl, pyridyl or unsubstituted or substituted phenyl; A is a ... | 03/26/1996 |
| 5494926 | 2/3-(heterocyclic alkyl amino)-1-(subst.-phenyl-methoxy)-ethanes/propanes as tachykinin-receptor antagonists Compounds of formula (I), and salts and prodrugs thereof, wherein Q represents phenyl or benzhydryl; X and Y each represent H or X and Y together form a group =0; Z is O, S or NR8 (R8 is H or C1-6 alkyl); R1 is ... | 02/27/1996 |
| 5484811 | Use of ethynyl alanine amino diol compounds for treatment of ophthalmic disorders Compounds characterized generally as ethynyl alanine amino diol derivatives are useful as renin inhibitors for the treatment of ophthalmic disorders. Compounds of particular interest are those of Formula I ##STR1## wherein A is selected from CO and S... | 01/16/1996 |
| 5484800 | Lipid-based liquid medicinal composition The present invention is directed to liquid medicinal suspension compositions for the administration of doses of active pharmaceutical agents such as H2 -antagonists. H2 -antagonists are known for their adverse taste and/or malodor a... | 01/16/1996 |
| 5484812 | Propargyl glycine amino use of propargyl diol compounds for treatment of ophthalmic disorders Compounds characterized generally as propargyl glycine amino propargyl diol derivatives are useful as renin inhibitors for the treatment of ophthalmic disorders. Compounds of particular interest are those of Formula I ##STR1## wherein A is selected f... | 01/16/1996 |
| 5482966 | Oxime derivatives The invention concerns oxime derivatives of the formula I ##STR1## wherein R4 includes hydrogen, carboxy, carbamoyl, amino, cyano, trifluoromethyl, (1-4C)alkylamino, di-(1-4C)alkylamino and (1-4C)alkyl; R5 includes hydrogen, (1-4C)al... | 01/09/1996 |
| 5478854 | Deoxy taxols Rg is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, or a radical of the formula --W--Rx in which W is a bond, C2-6 alkenediyl, or --(CH2)t --, in whic... | 12/26/1995 |
| 5476669 | Method for treatment of gastro intestinal disorders A method is disclosed for preventing the recurrence of duodenal ulcer associated with Campylobacter pylori (Helicobacter pylori) infection in a patient suffering from duodenal ulcer disease associated with Campylobacter pylori infection by administering a... | 12/19/1995 |
| 5474999 | Therapeutic amides Amides having formula I: ##STR1## wherein E, X, R2 and R3 have the meanings given in the specification, and pharmaceutically acceptable salts and pharmaceutically acceptable in vivo hydrolysable esters thereof, which are useful ... | 12/12/1995 |
| 5472984 | 1,2-ethanediol derivative and salt thereof and cerebral function-improving agent comprising the same This invention relates to a 1,2-ethanediol derivative and a salt thereof, a process for producing the same, and a cerebral function-improving agent comprising the same. The cerebral function-improving agent of this invention is useful for treating cerebro... | 12/05/1995 |
| 5468774 | Tetronic, thiotetronic and tetramic acid derivatives as phospholipase A.sub . There are disclosed compounds of the formula: ##STR1## wherein X is O; R1 and R2 are each, independently, hydrogen, C1 -C10 alkyl, C3 -C20 cycloalkyl, phenylloweralkyl, or substituted ... | 11/21/1995 |
| 5466690 | Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity Retinoid-like activity is exhibited by compounds of the formula ##STR1## where R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is H, --COOH or an ester or amide thereof, --CH2 | 11/14/1995 |
| 5462963 | Chelator compositions comprising -diamine compounds The present invention involves photoprotective compositions which are useful for topical application to prevent damage to skin caused by acute or chronic exposure to ultraviolet light comprising chelating agents having the structure: ##STR1## wh... | 10/31/1995 |
| 5462939 | Peptidic ketones as interleukin-1ଲ-converting enzyme inhibitors Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein R1 is (CR5 R6)n, (CR5 R6)n -aryl, (CR5 R6) | 10/31/1995 |
| 5457131 | Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents The present invention relates to cyclopentane heptanoic or cyclopentane heptenoic acid, 2-hydrocarbyl sulfonamidomethyl, and derivatives thereof, useful as therapeutic agents. In particular, the therapeutic agents of this invention are useful as ocular hy... | 10/10/1995 |
| 5457125 | Oxime derivatives The invention concerns oxime derivatives of the formula I ##STR1## wherein R4 is hydrogen, (1-4C)alkyl, halogeno-(2-4C)alkyl, hydroxy-(2-4C)alkyl, cyano-(1-4C)alkyl, phenyl or phenyl-(1-4C)alkyl; R5 is hydrogen, (1-4C)alkyl, halogeno... | 10/10/1995 |
| 5456925 | Pharmaceutical compositions containing furan derivatives The invention relates to a pharmaceutical composition in solid unit dosage form adapted for oral administration, comprising a salt formed between ranitidine and a complex of bismuth with a carboxylic acid selected from tartaric acid and citric acid togeth... | 10/10/1995 |
| 5455265 | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors Process of treatment of mammals, including humans to treat diseases or conditions of the type which are normally treated with retinoid-like compounds is disclosed, with pharmaceutical compositions containing an active compound which is a selective agonist... | 10/03/1995 |
| 5453428 | Method and composition for the treatment of apathy-amotivation syndrome In accordance with the present invention, neuropsychiatric symptoms of apathy-amotivation syndrome and particularly those symptoms in: Alzheimer's disease, multiple sclerosis, Huntington's chorea, frontal lobe lesions, and AIDS dementia can be ameliorated... | 09/26/1995 |
| 5447918 | Gastrointestinal anti-irritant composition comprising sucralfate and methods of use A composition comprising sucralfate and one or more anti-acid epigastralgic relieving agents in a weight ratio of between 0.5:1.0 to 1.3 sucralfate to anti-acid epigastralgic relieving agent and a method of using the composition for relieving symptoms of ... | 09/05/1995 |
| 5447942 | N-derivatives of (phenylethyl-ଲ-ol) amine, a process for their preparation and pharamaceutical compositions containing the same The invention relates to a N-(2,4- or 2,5-disubstituted tetrahydrofuryl alkyl)-N-(phenylethyl-ଲ-ol)amine derivative, under a racemic or enantiomer form, of general formula I ##STR1## wherein R represent various radicals and n is of from 1 to 10... | 09/05/1995 |
| 5446067 | Oxime ethers and fungicides containing them Oxime ethers of the formula ##STR1## wherein m, G, R, R1, X, Y, and Z are as defined herein and fungicides containing these compounds.... | 08/29/1995 |
| 5441974 | Phenyl amidines lactones useful as platelet aggregation inhibitors This invention relates to compounds having the following formula ##STR1## wherein Z is a lactone or a lactone which is fused to a benzene ring which are useful in the inhibition of platelet aggregation. This invention also relates to pharmaceutical c... | 08/15/1995 |
| 5438056 | Heterocyclic oxime carbamates The compounds of the present invention have the following formula: ##STR1## wherein R1 and R2 are independently phenyl, pyridyl, thienyl, naphthyl, substituted phenyl wherein the substituent is selected from the group consisting... | 08/01/1995 |
| 5436244 | Indane derivatives and analgesic and diuretic compositions thereof Novel indanes in all possible stereoisomer forms of the formula ##STR1## wherein the substituents are as defined in the specification and their non-toxic, pharmaceutically acceptable acid addition salts and their hydrates having central analgesic pro... | 07/25/1995 |
| 5436252 | 5-aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders This invention relates to neuroprotective 5-aryl-3H-1,2,4-triazol-3-ones and to their use in the treatment of neurodegenerative disorders such as cerebral ischemia, stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease.... | 07/25/1995 |
| 5434151 | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase 2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respira... | 07/18/1995 |
